论文首页哲学论文经济论文法学论文教育论文文学论文历史论文理学论文工学论文医学论文管理论文艺术论文 |
6 Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin- converting enzyme inhibitors. N Engl J Med,1993,329:1-7.
7 Ward RE, Gheorghiade M, Young JB, et al. Economic outcomes of withdrawal of digoxin in therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol,1995,26:93-101.
8 Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med,1997,336:525-533.
9 Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin on the treatment of heart failure. N Engl J Med,2002,347:1403-1411.
10 Adams KF Jr, Gheorghiade M, Uretsky BF, et al. Clinical benefits of low serum digoxin concentration in heart failure. J Am Coll Cardiol,2002,39:946-953.
11 Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med,1999,341:709-717.
12 Richardson A, Scriven AJ, Poole-Wilson PA, et al. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet,1987,2:709-711.